S&P 500 7,623.68 −0.52%
Nasdaq 25,955.34 −0.21%
S&P/TSX 35,788.18 −0.52%
Apple 347.73 −0.14%
Nvidia 210.96 −0.59%
Microsoft 524.51 +0.66%
Shopify 236.24 −0.07%
Royal Bank 281.77 −0.36%
CAD/USD 0.7141 −0.01%
CLOSED · 03:30 ET
Market ClerkRecap
Sat Oct 24 · markets closed6 signals on Oct 2394 insider buys this week · $48.3MCIRO short report next: Oct 30The week ahead
SJ
INSIDER · TXG · 10x Genomics, Inc. · DIRECTOR

STUELPNAGEL JOHN R

Every open-market transaction filed under this name, Sep 3 to Sep 3.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$1.2M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 3TXG10x Genomics, Inc.DirectorSell6,174$62.61$387K—
Sep 3TXG10x Genomics, Inc.DirectorSell6,814$62.11$423K—
Sep 3TXG10x Genomics, Inc.DirectorSell7,012$60.66$425K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.